Palatin Technologies (PTN)
(Delayed Data from AMEX)
$1.49 USD
+0.01 (0.68%)
Updated Sep 9, 2024 04:00 PM ET
After-Market: $1.47 -0.02 (-1.34%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Palatin Technologies, Inc. [PTN]
Reports for Purchase
Showing records 61 - 80 ( 201 total )
Company: Palatin Technologies, Inc.
Industry: Medical - Biomedical and Genetics
F2019 Results; Vyleesi Now Being Marketed; Focus on Key Pipeline Expansion
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Palatin Technologies, Inc.
Industry: Medical - Biomedical and Genetics
The Time Has Come for Vyleesi; Next Chapter Begins Plus a $60M Check; Target Increased to $7.50
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Palatin Technologies, Inc.
Industry: Medical - Biomedical and Genetics
AMAG Highlights Vyleesi''s Commercial Profile at Analyst Day; Stage Set for 3Q19 Launch
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Palatin Technologies, Inc.
Industry: Medical - Biomedical and Genetics
AMAG Highlights Vyleesi''s Commercial Profile at Analyst Day; Stage Set for 3Q19 Launch
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Palatin Technologies, Inc.
Industry: Medical - Biomedical and Genetics
It''s Time to Get Excited; Vyleesi?s PDUFA Is June 23; Target Increased to $6
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Palatin Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Vyleesi Data Inserted Into NDA as Expected; PL-8177 Data Bringing up the Rear; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Palatin Technologies, Inc.
Industry: Medical - Biomedical and Genetics
F2Q19 Results; Growing Anticipation Ahead of June PDUFA for Vyleesi; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Palatin Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Full Release From Phase 1 Should Come Soon Leading to Full Approval and a $60 Million Check
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Palatin Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: Palatin Technologies, Inc.
Industry: Medical - Biomedical and Genetics
F2018 Results; It''s All About Vylessi Ahead of PDUFA Date; We Think Drug Is In Enticing Position; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Palatin Technologies, Inc.
Industry: Medical - Biomedical and Genetics
We are dropping coverage of PTN shares to reallocate our research resources
Provider: Roth Capital Partners, Inc.
Company: Palatin Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Addyi Relaunches; Still Trying to put a Square Peg in a Round Hole; First-to-Market Status Still not a Selling Point
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Palatin Technologies, Inc.
Industry: Medical - Biomedical and Genetics
NDA Accepted; Have a Drink and Cash a Check; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Palatin Technologies, Inc.
Industry: Medical - Biomedical and Genetics
F3Q18 Results; Hot and Heavy Preparations for AdCOM; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Palatin Technologies, Inc.
Industry: Medical - Biomedical and Genetics
An Arousing Number of Major Boxes Checked; Initiating at Buy, $5 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Palatin Technologies, Inc.
Industry: Medical - Biomedical and Genetics
We are placing shares of PTN Under Review, and transferring coverage to ROTH Capital Research due to the departure of the covering analyst.
Provider: Roth Capital Partners, Inc.
Company: Palatin Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Company: Palatin Technologies, Inc.
Industry: Medical - Biomedical and Genetics
Qtr Inline, as Pipeline Continues to Advance; Reiterate Buy, $1.50 PT
Provider: Roth Capital Partners, Inc.
Analyst: HIGGINS M
Company: Palatin Technologies, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Palatin Technologies, Inc.
Industry: Medical - Biomedical and Genetics
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.